CIK 0000879169
- Large accelerated filer
INCYTE CORP
Sign in to watch- Ticker
- INCY
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943136539
- Phone
- +1 302-498-6700
- Business address
- 1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
- Former names
- INCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $32,959,897
- in 5 filings, $33.0M under 10b5-1 plans
Net −$32,959,897. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-02 | Hoppenot Herve Special Advisor to the CEO | Shares withheld for taxes | −42,769 | $68.17 | $2.9M | 526,820 |
| 2025-07-02 | Meury William Chief Executive Officer | Grant or award | +36,101 | 36,101 | ||
| 2025-07-02 | Meury William Chief Executive Officer | Grant or award · Performance Shares | +108,303 | 108,303 | ||
| 2025-07-02 | Meury William Chief Executive Officer | Grant or award · Performance Shares | +125,000 | 125,000 | ||
| 2025-06-30 | BAKER BROS. ADVISORS LP Director | Grant or award | +492 | 2,816,902 | ||
| 2025-06-30 | BAKER BROS. ADVISORS LP Director | Grant or award | +492 | 28,187,581 | ||
| 2025-06-30 | Clancy Paul J Director | Grant or award | +361 | $68.10 | $25K | 22,950 |
| 2025-06-30 | HARRIGAN EDMUND Director | Grant or award | +367 | $68.10 | $25K | 20,319 |
| 2025-06-30 | Issa Mohamed Khairie EVP, Head of US Oncology | Grant or award | +27,812 | 76,483 | ||
| 2025-06-26 | Meury William Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +110,630 | 110,630 | ||
| 2025-06-26 | Hoppenot Herve Special Advisor to the CEO | Grant or award | +6,016 | 569,589 | ||
| 2025-06-26 | Hoppenot Herve Special Advisor to the CEO | Grant or award · Employee Stock Option (right to buy) | +18,438 | 18,438 | ||
| 2025-06-26 | Hoppenot Herve Special Advisor to the CEO | Grant or award · Performance Shares | +18,050 | 18,050 | ||
| 2025-06-10 | BRAWLEY OTIS W Director | Grant or award | +2,518 | 11,252 | ||
| 2025-06-10 | BRAWLEY OTIS W Director | Grant or award · Non Qualfied Stock Option (right to buy) | +9,216 | 9,216 | ||
| 2025-06-10 | FOUSE JACQUALYN A Director | Grant or award | +2,518 | 19,326 | ||
| 2025-06-10 | FOUSE JACQUALYN A Director | Grant or award · Non Qualfied Stock Option (right to buy) | +9,216 | 9,216 | ||
| 2025-06-10 | BIENAIME JEAN JACQUES Director | Grant or award | +2,518 | 20,841 | ||
| 2025-06-10 | BIENAIME JEAN JACQUES Director | Grant or award · Non Qualfied Stock Option (right to buy) | +9,216 | 9,216 | ||
| 2025-06-10 | High Katherine A Director | Grant or award | +2,518 | 13,341 |
Page 20 of 25 · 500 trades